NCT04536571

Brief Summary

The principal hypothesis is to be tested in this work is that vision stability (the primary outcome measure) with a spherical contact lens correction vs. a toric contact lens correction will be the same.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2020

Completed
19 days until next milestone

First Posted

Study publicly available on registry

September 2, 2020

Completed
1 day until next milestone

Study Start

First participant enrolled

September 3, 2020

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 7, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 7, 2021

Completed
6 months until next milestone

Results Posted

Study results publicly available

November 22, 2021

Completed
Last Updated

November 22, 2021

Status Verified

November 1, 2021

Enrollment Period

9 months

First QC Date

August 14, 2020

Results QC Date

October 22, 2021

Last Update Submit

November 19, 2021

Conditions

Outcome Measures

Primary Outcomes (3)

  • Vision Stability While Doing Tasks on Mobile Phone

    Vision stability was assessed by study subjects while doing tasks on mobile phone using a 0-100 visual analogue scales (0 - Unacceptable. Lens cannot be worn, 100 - Excellent. Unaware of any visual loss)

    30 minutes

  • Vision Stability While Doing Tasks on Desktop

    Vision stability was assessed by study subjects while doing tasks on desktop using a 0-100 visual analogue scales (0 - Unacceptable. Lens cannot be worn, 100 - Excellent. Unaware of any visual loss)

    30 minutes

  • Vision Stability While Walking

    Vision stability was assessed by study subjects while walking using a 0-100 visual analogue scales (0 - Unacceptable. Lens cannot be worn, 100 - Excellent. Unaware of any visual loss)

    30 minutes

Secondary Outcomes (2)

  • Lens Fit for Test Contact Lens

    10 minutes

  • Lens Fit

    30 minutes

Study Arms (2)

Test Contact lens

EXPERIMENTAL

Subjects will be randomized to wear test lenses for 30 minutes, and then cross-over to control lenses.

Device: Test Contact lensDevice: Control Contact lens

Control Contact lens

ACTIVE COMPARATOR

Subjects will be randomized to wear control lenses for 30 minutes, and then cross-over to test lenses.

Device: Test Contact lensDevice: Control Contact lens

Interventions

Subjects will be randomized to wear test lenses for 30 minutes, and then cross-over to control lenses.

Also known as: Soft comfilcon A toric contact lenses
Control Contact lensTest Contact lens

Subjects will be randomized to wear control lenses for 30 minutes, and then cross-over to test lenses.

Also known as: Soft comfilcon A sphere contact lenses
Control Contact lensTest Contact lens

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • They are aged 18-35 years and have capacity to volunteer.
  • They understand their rights as a research subject and are willing and able to sign a Statement of Informed Consent.
  • They are willing and able to follow the protocol.
  • They are an existing wearer of soft spherical contact lenses in both eyes.
  • They have a spherical component of their spectacle refractive error between
  • DS and -6.50DS in both eyes.
  • They have a cylindrical component of their spectacle refractive error between
  • DC and -1.25DC in both eyes.
  • They can be fitted satisfactorily with both lens types.
  • They own an acceptable pair of spectacles.
  • They agree not to participate in other clinical research for the duration of the study.

You may not qualify if:

  • They have an ocular disorder which would normally contra-indicate contact lens wear.
  • They have a systemic disorder which would normally contra-indicate contact lens wear.
  • They are using any topical medication such as eye drops (including comfort drops) or ointment on a regular basis.
  • They are aphakic.
  • They have had corneal refractive surgery.
  • They have any corneal distortion resulting from previous hard or rigid lens wear or have keratoconus.
  • They are pregnant or breastfeeding.
  • They have any ocular abnormality which would, in the opinion of the investigator, normally contraindicate contact lens wear.
  • They have any infectious disease which would, in the opinion of the investigator, contraindicate contact lens wear or pose a risk to study personnel; or they have any immunosuppressive disease (e.g. HIV), or a history of anaphylaxis or severe allergic reaction.
  • They have taken part in any other contact lens or care solution clinical trial or research, within two weeks prior to starting this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eurolens Research

Manchester, M13 9PL, United Kingdom

Location

MeSH Terms

Conditions

AstigmatismMyopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Results Point of Contact

Title
Jose A. Vega, O.D, MSc., FAAO
Organization
CooperVision. Inc

Study Officials

  • Philip Morgan, PhD.

    University of Manchester

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 14, 2020

First Posted

September 2, 2020

Study Start

September 3, 2020

Primary Completion

June 7, 2021

Study Completion

June 7, 2021

Last Updated

November 22, 2021

Results First Posted

November 22, 2021

Record last verified: 2021-11

Data Sharing

IPD Sharing
Will not share

Locations